| Intestinal microbiota in type 2 diabetes and chronic kidney disease A Sabatino, G Regolisti, C Cosola, L Gesualdo, E Fiaccadori Current diabetes reports 17, 1-9, 2017 | 190 | 2017 |
| Effect of whole-grain barley on the human fecal microbiota and metabolome M De Angelis, E Montemurno, L Vannini, C Cosola, N Cavallo, G Gozzi, ... Applied and environmental microbiology 81 (22), 7945-7956, 2015 | 179 | 2015 |
| Nutritional treatment of advanced CKD: twenty consensus statements A Cupisti, G Brunori, BR Di Iorio, C D’Alessandro, F Pasticci, C Cosola, ... Journal of nephrology 31, 457-473, 2018 | 151 | 2018 |
| What would you like to eat, Mr CKD Microbiota? A Mediterranean Diet, please! E Montemurno, C Cosola, G Dalfino, G Daidone, M De Angelis, ... Kidney and Blood Pressure Research 39 (2-3), 114-123, 2014 | 115 | 2014 |
| Nutritional therapy modulates intestinal microbiota and reduces serum levels of total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease (Medika Study) BR Di Iorio, MT Rocchetti, M De Angelis, C Cosola, S Marzocco, ... Journal of clinical medicine 8 (9), 1424, 2019 | 101 | 2019 |
| Non-traditional aspects of renal diets: focus on fiber, alkali and vitamin K1 intake A Cupisti, C D’Alessandro, L Gesualdo, C Cosola, M Gallieni, MF Egidi, ... Nutrients 9 (5), 444, 2017 | 93 | 2017 |
| Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease C Cosola, MT Rocchetti, A Cupisti, L Gesualdo Pharmacological Research 130, 132-142, 2018 | 85 | 2018 |
| Bone morphogenetic protein-2 may represent the molecular link between oxidative stress and vascular stiffness in chronic kidney disease G Dalfino, S Simone, S Porreca, C Cosola, C Balestra, C Manno, ... Atherosclerosis 211 (2), 418-423, 2010 | 83 | 2010 |
| Beta-glucans supplementation associates with reduction in p-cresyl sulfate levels and improved endothelial vascular reactivity in healthy individuals C Cosola, M De Angelis, MT Rocchetti, E Montemurno, V Maranzano, ... PloS one 12 (1), e0169635, 2017 | 79 | 2017 |
| Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease BR Di Iorio, S Marzocco, A Bellasi, E De Simone, F Dal Piaz, MT Rocchetti, ... Nephrology Dialysis Transplantation 33 (5), 804-813, 2018 | 72 | 2018 |
| Microbiota issue in CKD: how promising are gut-targeted approaches? C Cosola, MT Rocchetti, A Sabatino, E Fiaccadori, BR Di Iorio, ... Journal of nephrology 32, 27-37, 2019 | 66 | 2019 |
| Dietary protein and nutritional supplements in conventional hemodialysis A Sabatino, G Piotti, C Cosola, I Gandolfini, JP Kooman, E Fiaccadori Seminars in dialysis 31 (6), 583-591, 2018 | 44 | 2018 |
| BMP-2 induces a profibrotic phenotype in adult renal progenitor cells through Nox4 activation S Simone, C Cosola, A Loverre, M Cariello, F Sallustio, F Rascio, ... American Journal of Physiology-Renal Physiology 303 (1), F23-F34, 2012 | 39 | 2012 |
| Microbiome modulation to correct uremic toxins and to preserve kidney functions G Caggiano, C Cosola, V Di Leo, M Gesualdo, L Gesualdo Current Opinion in Nephrology and Hypertension 29 (1), 49-56, 2020 | 35 | 2020 |
| Efficacy of divinylbenzenic resin in removing indoxyl sulfate and p-cresol sulfate in hemodialysis patients: Results from an in vitro study and an in vivo pilot trial (xuanro4 … MT Rocchetti, C Cosola, I di Bari, S Magnani, V Galleggiante, L Scandiffio, ... Toxins 12 (3), 170, 2020 | 34 | 2020 |
| An innovative synbiotic formulation decreases free serum indoxyl sulfate, small intestine permeability and ameliorates gastrointestinal symptoms in a randomized pilot trial in … C Cosola, MT Rocchetti, I di Bari, PM Acquaviva, V Maranzano, ... Toxins 13 (5), 334, 2021 | 33 | 2021 |
| Nutrients, nutraceuticals, and xenobiotics affecting renal health C Cosola, A Sabatino, I Di Bari, E Fiaccadori, L Gesualdo Nutrients 10 (7), 808, 2018 | 30 | 2018 |
| Obesity-related chronic kidney disease: principal mechanisms and new approaches in nutritional management A Stasi, C Cosola, G Caggiano, MT Cimmarusti, R Palieri, PM Acquaviva, ... Frontiers in Nutrition 9, 925619, 2022 | 28 | 2022 |
| Ketoanalogs’ effects on intestinal microbiota modulation and uremic toxins serum levels in chronic kidney disease (Medika2 Study) MT Rocchetti, BR Di Iorio, M Vacca, C Cosola, S Marzocco, I di Bari, ... Journal of clinical medicine 10 (4), 840, 2021 | 27 | 2021 |
| Protein-bound uremic toxins and immunity MT Rocchetti, C Cosola, E Ranieri, L Gesualdo Cytotoxic T-Cells: Methods and Protocols, 215-227, 2021 | 14 | 2021 |
Loreto GesualdoProfessore Ordinario di NefrologiaVerified email at uniba.it
